The healthcare industry’s commitment to addressing rare neurological disorders has reached unprecedented levels, with cataplexy management emerging as a priority therapeutic area. This condition, characterized by sudden episodes of bilateral muscle weakness triggered by emotional stimuli, represents one of the most challenging aspects of narcolepsy treatment. The Cataplexy Treatment Market has witnessed remarkable transformation over Read.